Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Impact of deep neuromuscular block versus inhalation and TIVA on laparoscopic surgical workspace
2013-002581-39Phase 4Completed
- Sponsor
- AZ Sint-Jan Brugge
- Start
- Apr 2014
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of remifentanil, sevoflurane and rocuronium in obesity (3 arms), sponsored by AZ Sint-Jan Brugge. Primary endpoint: Primary endpoint: Effect of high-dose remifentanil vs deep neuromuscular block on laparoscopic surgical workspace. Started Apr 2014; status: completed.
02
Drugs
remifentanilsevofluranerocuronium
03
Conditions
obesity
Beyond the preview
Go deeper on 2013-002581-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-002581-39.